Children with lupus nephritis who receive belimumab achieve treatment targets faster, and can taper glucocorticoids earlier, than those using standard immunotherapy, according to data published in ...

lupus nephritis, idiopathic inflammatory myopathy, and diffuse cutaneous systemic sclerosis. This effort aligns with Century’s ongoing Phase 1 CALiPSO-1 trial, which similarly evaluates CNTY-101’s ...

to assess therapies for initial management of lupus nephritis (LN), focusing on their design with study populations and outcomes, examining the results and identifying gaps that should be addressed in ...

1 The purpose of ALMS was to demonstrate the superiority of mycophenolate mofetil (MMF) over intravenous cyclophosphamide for the induction of remission in patients with lupus nephritis.

The use of SGLT2 vs DPP4 inhibitors was linked to reduced cardiovascular and renal risks among patients with comorbid SLE and T2D.

PHILADELPHIA - Century Therapeutics, Inc. (NASDAQ: IPSC), a biotechnology firm with a market capitalization of $77.32 million ...

Enhancing clinical research in India with publicly accessible histopathological image datasets for cancer and kidney disease ...

Hyderabad: IIIT Hyderabad, in collaboration with Nizam's Institute of Medical Sciences (NIMS), has released digitised ...

Caribou Biosciences (CRBU) announced initiation of the GALLOP Phase 1 clinical trial evaluating CB-010 in patients with lupus nephritis and ...

Hyderabad:IIIT Hyderabad (IIIT-H) and Nizam’s Institute of Medical Sciences (NIMS) have launched India’s first publicly ...

About 100 days into the CEO role at Kyverna Therapeutics, Warner Biddle has determined the strategic priorities for the ...